Bosentas 62.5mg (Bosentan Monohydrate) 62.5mg

Bosentas 62.5mg contains Bosentan Monohydrate, a medication used to manage pulmonary arterial hypertension. This 62.5mg strength tablet supports vascular function in adults and children. Store between 15-25°C to maintain potency. Always follow healthcare provider guidance when using this treatment.

Strength

62.5mg

Pack Size

20s

Storage

15 -25ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bosentas 62.5mg is prescribed to improve exercise capacity and symptoms in pulmonary arterial hypertension. It helps relax blood vessels in the lungs, reducing strain on the heart. Patients with WHO Group 1 PAH may benefit from this therapy. Consult a doctor to determine suitability for your condition.

Side Effects

Common effects include headache, flushing, and swelling in the legs or ankles. Some users report nasal congestion or low blood pressure after taking the medication. These effects are generally mild and temporary. Monitor your body’s response and report persistent issues to your healthcare team.

Precautions & Warnings

Keep Bosentas 62.5mg in its original packaging away from moisture and direct light. Avoid crushing or splitting tablets unless directed by a professional. Pregnant individuals or those planning pregnancy should discuss risks with their doctor. Regular liver function tests are recommended during treatment.

Avoid Interactions

Bosentas 62.5mg may interact with hormonal contraceptives, reducing their effectiveness. Avoid grapefruit products as they can alter how the medication works. Discuss all current medications, including over-the-counter drugs, with your healthcare provider before starting this treatment.

Frequently Asked Questions

Bosentas 62.5mg is used to treat pulmonary arterial hypertension in adults and children.

Store Bosentas 62.5mg between 15-25°C in its original packaging to protect it from moisture and light.

Consult your doctor before combining Bosentas 62.5mg with other drugs, as interactions may occur.

Common side effects include headache, flushing, and swelling in the legs or ankles.

Bosentas 62.5mg may harm an unborn baby; discuss risks with your healthcare provider if pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.